What is the most recent earnings date for ACST stock?
ACASTI PHARMA INC (ACST) last reported earnings on 8/9/2024.
ACASTI PHARMA INC (ACST) Earnings History & Surprises
NASDAQ:ACST • CA00430K8656
Current stock price
3.37 USD
-0.03 (-0.88%)
At close:
3.38 USD
+0.01 (+0.3%)
After Hours:
ACST Earnings overview
Past quarterly earnings results for ACASTI PHARMA INC (ACST), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Nov 11, 2024
- Period
- Q2 / 2025
- EPS Estimate
- -$0.64
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Aug 9, 2024
- Period
- Q1 / 2025
- EPS Reported
- -$0.37
- EPS Surprise
- -6.26%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -0.37 | -0.35 | -6.26% | -202.29% | - | - | ||
| Q4 2024 | -0.18 | -0.48 | 62.63% | 95.38% | - | - | ||
| Q3 2024 | -0.30 | -0.32 | 5.54% | 44.63% | - | - | ||
| Q2 2024 | -0.19 | -0.11 | -69.34% | -72.73% | - | - | ||
| Q1 2024 | -0.12 | - | -22.40% | - | - | |||
| Q4 2023 | -3.90 | -0.86 | -355.18% | -390.20% | - | - | ||
| Q3 2023 | -0.54 | -0.94 | 42.72% | 20.35% | - | - | ||
| Q2 2023 | -0.11 | - | - | - | - | |||
| Q1 2023 | -0.10 | - | - | - | - | |||
| Q4 2022 | -0.80 | - | - | - | -100.00% | |||
| Q3 2022 | -0.68 | -0.49 | -38.48% | - | - | -100.00% | ||
| Q2 2022 | - | - | - | - | ||||
| Q1 2022 | - | - | - | - | ||||
| Q4 2021 | - | - | 120K | - | - | |||
| Q3 2021 | - | - | 80K | - | - | |||
| Q2 2021 | -0.10 | -0.65 | 84.07% | 96.18% | - | - | ||
| Q1 2021 | -0.55 | -0.57 | 3.36% | 54.00% | - | - | ||
| Q4 2020 | 1.94 | -0.90 | 315.69% | - | - | - | ||
| Q3 2020 | -0.01 | - | - | - | - | |||
| Q2 2020 | -2.72 | -0.73 | -270.37% | - | - | - | ||
| Q1 2020 | -1.20 | -1.14 | -5.04% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-1.86%
Max EPS beat (4)
62.63%
Min EPS beat (4)
-69.34%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ACST has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, ACST reported -1.9% below the EPS estimates on average.
Related analysis
ACASTI PHARMA INC / ACST Earnings FAQ
Can you provide information on whether ACASTI PHARMA INC beat earnings estimates in the last quarter?
ACASTI PHARMA INC (ACST) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does ACST stock beat earnings estimates?
In the last 4 quarters, ACASTI PHARMA INC (ACST) has beaten EPS estimates in 2 out of 4 releases.